Sarepta Refused FDA’s Request to Halt Elevidys Shipments
[ad_1] (Bloomberg) — Sarepta Therapeutics Inc. has refused to pause all shipments of its Elevidys therapy after three deaths have been linked to the corporate’s gene therapies, the Meals and Drug Administration stated Friday. Two teenage boys died of acute liver failure in latest months after taking Elevidys. They have been being handled for Duchenne … Read more